FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to pharmaceutics and discloses a pharmaceutical composition comprising testosterone undecanoate and a solvent system, more specifically a pharmaceutical formulation containing testosterone undecanoate in amount of 6 % to 12 % by weight, propylene glycol, propylene glycol monocaprylate, polyethoxylated castor oil and digestible ester of a long-chain fatty acid.
EFFECT: invention provides more rapid and higher duration of testosterone absorption undecanoate and can be used for treating hypogonadism.
11 cl, 9 tbl
Authors
Dates
2019-12-05—Published
2015-06-15—Filed